LIn terms of options trading activity among constituents of the Russell 3000 Index, there was notable activity today at Integra LifeSciences Holdings Corp (Symbol: IART), where total volume of 2,482 contracts has been traded so far today, a volume of contracts that is representative of approximately 248,200 underlying stocks (given that each contract represents 100 underlying stocks). This number equates to 50% of the IART’s average daily trading volume over the past month, or 496,610 shares. Particularly high volume was seen for the $65 strike put option expiring May 20, 2022, with 1,239 contracts traded so far today, representing approximately 123,900 underlying IART shares. Below is a chart showing IART’s trading history over the past twelve months, with the $65 strike highlighted in orange:
Riot Blockchain Inc’s options (ticker: RIOT) have a volume of 53,923 contracts to date. This number of contracts represents approximately 5.4 million underlying shares, or 49.1% of RIOT’s average daily trading volume over the past month, or 11.0 million shares. Particularly high volume was seen for the $8 strike call expiring May 20, 2022, with 6,924 contracts traded so far today, representing approximately 692,400 underlying RIOT shares. Below is a chart showing RIOT’s 12-month trading history, with the $8 strike highlighted in orange:
And Clorox Co Options (ticker: CLX) is showing 7,701 contracts volume so far today. This number of contracts represents approximately 770,100 underlying stocks, or 48.9% of CLX’s average daily trading volume over the past month, or 1.6 million shares. Particularly high volume was seen for the $145 strike put option expiring July 15, 2022, with 1,644 contracts traded so far today, representing approximately 164,400 underlying CLX shares. Below is a chart showing CLX’s past twelve month trading history, with the $145 strike highlighted in orange:
For the different expirations available for IART options, RIOT options or CLX options, visit StockOptionsChannel.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
